XML 21 R11.htm IDEA: XBRL DOCUMENT
v3.25.3

ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE | 3 Months Ended
--- | ---
Sep. 30, 2025
Receivables [Abstract] |
ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE | NOTE 3 – ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE Receivables, net are comprised of the following at September 30, 2025 and June 30, 2025:
Schedule of financing receivable noncurrent allowance for credit loss |  |  |  |  |  |  |  |  |  |  |  |
|  | September 30, 2025
|  | Gross Receivable |  | Allowance for credit losses |  | Net
Accounts receivable |  | $ | 5,406 |  |  | $ | 260 |  |  | $ | 5,146 |
Accounts receivable - related party |  | $ | 90 |  |  | $ | — |  |  | $ | 90 |
Medical receivable |  | $ | 24,486 |  |  | $ | — |  |  | $ | 24,486 |
Management and other fees receivable |  | $ | 58,585 |  |  | $ | 13,866 |  |  | $ | 44,719 |
Management and other fees receivable from related medical practices (“PC’s”) |  | $ | 17,693 |  |  | $ | 7,666 |  |  | $ | 10,027 |
|  | June 30, 2025
|  | Gross Receivable |  | Allowance for credit losses |  | Net
Accounts receivable |  | $ | 5,569 |  |  | $ | 264 |  |  | $ | 5,305 |
Medical receivable |  | $ | 24,490 |  |  | $ | — |  |  | $ | 24,490 |
Management and other fees receivable |  | $ | 57,697 |  |  | $ | 14,296 |  |  | $ | 43,401 |
Management and other fees receivable from related medical practices (“PC’s”) |  | $ | 16,885 |  |  | $ | 7,137 |  |  | $ | 9,748 |
The Company’s customers are concentrated in the healthcare industry. Accounts Receivable Credit risk with respect to the Company’s accounts receivable related to product sales and service and repair fees is limited due to the customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services if accounts receivable become past due. The Company has established a current expected credit loss (“CECL”) to address the risk that a portion of these fees will not be paid. The Company controls credit risk with respect to accounts receivable from service and repair fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided. The following tables presents information related to the allowance for credit losses that relate to accounts and management and other fees receivable:
Schedule of Summary of Allowance For Credit Losses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Summary of Allowance For Credit Losses
Description |  | Balance June 30, 2025 |  | Additions (Recovery) |  | Deductions |  | Balance Sept. 30, 2025
Accounts receivable |  | $ | 264 |  |  | $ | — |  |  | $ | (4 | ) |  | $ | 260 |
Management and other fees receivable |  |  | 14,296 |  |  |  | (430 | ) |  |  | — |  |  |  | 13,866 |
Management and other fees receivable - related medical practices |  |  | 7,137 |  |  |  | 529 |  |  |  | — |  |  |  | 7,666 |
|  | Balance |  |  |  |  |  | Balance
Description |  | June 30, 2024 |  | Additions (Recovery) |  | Deductions |  | June 30, 2025
Accounts receivable |  | $ | 166 |  |  | $ | 107 |  |  | $ | (9 | ) |  | $ | 264 |
Management and other fees receivable |  |  | 12,370 |  |  |  | 2,052 |  |  |  | (126 | ) |  |  | 14,296 |
Management and other fees receivable - related medical practices |  |  | 6,110 |  |  |  | 1,027 |  |  |  | — |  |  |  | 7,137 |
Long Term-Accounts Receivable Long term-accounts receivable balances at September 30, 2025 and June 30, 2025 amounted to approximately $3,471 and $3,550, respectively. The Company will generate revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to be recognized over the following four years as of September 30, 2025 is as follows:
| Schedule of future revenue |  |  |  |  |
| 2026 |  |  | $ | 1,550 |
| 2027 |  |  |  | 1,012 |
| 2028 |  |  |  | 893 |
| 2029 |  |  |  | 227 |
| Total |  |  | $ | 3,682 |
Medical Receivables Medical receivables are due under fee-for-service contracts from third-party payors, such as hospitals, government sponsored healthcare programs, patient’s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. Medical receivables are recorded at net realizable value based on the estimated amounts the Company expects to receive from patients and third-party payors. The medical receivable is reduced by contractual adjustments based on the historical experience with each payor class at each location. Management and Other Fees Receivable Management fees receivable is related to management fees outstanding from the related and non-related centers under management agreements. The Company has established a CECL reserve to address the risk that a portion of the contractually obligated management fees receivable from the PCs may not be paid. The PCs may be limited in their ability to pay the full management fee receivable if they do not collect sufficient expected fees from third-party payers and patients. The Company’s management fees are collateralized, individually and collectively, by the assets of the PCs. The CECL reserve is determined based on the difference between the management fee receivable and the current amount of outstanding fees estimated to be collected by the PCs. The Company’s considerations into the estimate of the PCs’ fee collection is based on a combination of factors. As each management agreement specifies the Company’s ultimate collateral for unpaid management fees are the patient fee receivables owned by each PC, the Company considers the historical loss rates to pools of receivables with similar risks characteristics, aging of the patient fee receivables, and the financial condition of each PC. In addition, the Company subjectively adjusts its estimated expected credit losses for current and forward-looking economic conditions which would include trends seen within the industry and newly enacted regulations. The Company also incorporates qualitative factors, such as changes in the nature and volume of receivables, regulatory changes, and other relevant factors. Specifically, insurance carriers covering automobile no-fault and workers’ compensation claims incur longer payment cycles, rigorous informational requirements and certain other disallowed claims. The Company combines an objective and subjective loss-rate methodology to estimate expected credit losses based on the collateral owned by each PC. This involves objectively using historical loss rates to pools of receivables with similar risk characteristics (i.e., various insurance payors) and then subjectively adjusting for current and forward-looking economic conditions which would include trends seen within the industry and newly enacted regulations. The Company also incorporates qualitative factors, such as changes in the nature and volume of the receivables, regulatory changes, and other relevant factors. Additional Company managed entities also operate under a guaranty agreement, pursuant to which management fees are payable to the Company. For LLCs owned by the Company, approximately 63.7% and 68.3% of net revenues were derived from no-fault and personal injury protection for the three months ended September 30, 2025 and 2024, respectively. Net revenues from management and other fees charged to the related PCs accounted for approximately 11% and 12.0% of the consolidated net revenues for the three months ended September 30, 2025 and 2024, respectively.

X
- Definition The entire disclosure for claims held for amounts due to entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/310-10/tableOfContent Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 835 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2 + Details
Name: | us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ReceivablesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration